Programme TEST PAGE - Intelligent Health
Tickets

Programme TEST PAGE

 

 

    Active Filters
  • Wednesday 13th
  • 07:30 - 09:20
    REGISTRATION
  • 09:20 - 09:30
    WELCOME Inspired Minds Sarah Porter, CEO and Founder, InspiredMinds! UN Advisor, LAWS Main Stage
    • Sarah Porter, CEO and Founder, InspiredMinds! UN Advisor, LAWS

  • 09:25 - 09:30
    WELCOME Novartis Foundation Dr Ann Aerts, Head of the Novartis Foundation Main Stage
    • Dr Ann Aerts, Head of the Novartis Foundation

  • 09:35 - 09:40
    WELCOME and chairs' opening remarks Alexander Finlayson, CEO & Founder, Nye Health, NHS Primary Care Doctors & Doll Fellow, Oxford University
    Maxine Mackintosh, Co- Founder, One HealthTech     Main Stage
    • Alexander Finlayson, CEO & Founder, Nye Health, NHS Primary Care Doctors & Doll Fellow, Oxford University

    • Maxine Mackintosh, Co- Founder, One HealthTech

  • 09:40 - 10:05
    HEADLINER: How AI is revolutionizing Healthcare - leading to Precision Care Roland Rott, President & CEO Ultrasound, GE HealthCare Main Stage

    Artificial intelligence is rapidly transforming healthcare, with the promise to help harness data for actionable insights, reduce adverse events, augment human intelligence and elevate care teams. In this session, Roland Rott will examine an increasingly complex healthcare environment, and show how AI—by addressing some of the most pressing healthcare challenges—is helping improve quality and patient outcomes, and creating a more human and flexible healthcare experience.

    • Roland Rott, President & CEO Ultrasound, GE HealthCare

  • 10:05 - 10:30
    HEADLINER: AI in Healthcare. What’s new? Mona Flores, Global Head of Medical AI, Nvidia Main Stage

    AI is changing healthcare as we know it. It is augmenting our abilities, and with new training paradigms, platforms and computing methods, ​it will revolutionize healthcare delivery, and get us to the holy grail, precision medicine. ​This talk will cover the  advances in AI that will change healthcare including generative AI and Large Language Models

    • Mona Flores, Global Head of Medical AI, Nvidia

  • 10:30 - 10:55
    HEADLINER: AI4HealthyCities – better evidence to address health inequities Peter Speyer, Head of Data, Analytics & AI, Novartis Foundation Main Stage

    Even though cardiovascular diseases are mostly preventable, they cause 18M deaths per year. Improving outcomes and reducing inequities in heart health requires precision health – cross-sectoral action informed by better evidence. The Novartis Foundation’s AI4HealthyCities initiative uses a multi-pronged approach to identify the key drivers of heart health and disease across genetic, behavioral and social determinants with advanced analytics and AI. The initiative works with a broad set of collaborators and stakeholders to systematically review existing evidence, analyze detailed data in multiple cities, and develop much-needed evidence to inform urban population health roadmaps.

    • Peter Speyer, Head of Data, Analytics & AI, Novartis Foundation

  • 10:55 - 11:30
    REFRESHMENTS & NETWORKING
  • INTELLIGENT HEALTH: PLENARY
    • 11:30 - 11:50
      Reimagining Better Health: The potential of Foundation models Jan Beger, Senior Director Digital Ecosystem, GE HealthCare

      The exceptionally rapid advancement of highly flexible and reusable AI models is poised to introduce new capabilities in the field of medicine. These latest-generation AI systems, known as foundation models, are trained on large, diverse datasets and can be adapted for a wide array of downstream tasks. This adaptability marks a significant departure from earlier AI models, which were tailored to address individual tasks one by one. With their transformative potential, foundation models not only stand to revolutionize healthcare but also enable technology providers to scale AI deployment more effectively.

      • Jan Beger, Senior Director Digital Ecosystem, GE HealthCare

    • 11:50 - 12:30
      PANEL DISCUSSION: Examining the latest regulatory challenges and how to navigate them in order to bring AI solutions to market and ensure appropriate monitoring post-implementation Francesca Cipolli, Associate Director Global Regulatory Precision Medicine, Bristol Myers Squibb
      Brenna Loufek, SaMD Regulatory Affairs Lead, Mayo Clinic / University of Oxford
      Dr. Felice Burn, Head of Artificial Intelligence & Data Science, Kantonsspital Aarau AG
      Moderator:
      Dr Elisabeth Zeaiter, Health Data Insights Director, Global Clinical Operations, Novartis
      • How to benchmark different AI technologies 
      • The need for guidelines and protocols for AI models
      • Francesca Cipolli, Associate Director Global Regulatory Precision Medicine, Bristol Myers Squibb

      • Brenna Loufek, SaMD Regulatory Affairs Lead, Mayo Clinic / University of Oxford

      • Dr. Felice Burn, Head of Artificial Intelligence & Data Science, Kantonsspital Aarau AG

      • Moderator:

      • Dr Elisabeth Zeaiter, Health Data Insights Director, Global Clinical Operations, Novartis

    • 12:30 - 12:50
      HEADLINER: AI and the transformation of surgery Professor Shafi Ahmed, Futurist and Innovator - Consultant Surgeon, Barts Health NHS Trust - CEO, Medical Realities

      Surgery is being transformed from analogue to digital with the promise of AI and data-driven outcomes. From surgical navigation and extended reality to robots and 5G remote autonomous surgery, the digital surgeon will have to embrace these technologies to improve patient care

      • Professor Shafi Ahmed, Futurist and Innovator - Consultant Surgeon, Barts Health NHS Trust - CEO, Medical Realities

  • TRACK 1: PRACTICAL, REAL-WORLD AI USE CASES IN HEALTHCARE Stefan Naeff, Digital Health Care Lead for Switzerland, Deloitte Consulting AG
    • 11:30 - 11:50
      HEADLINER USE CASE: Opening a fully digital hospital in Central London; Revolutionizing the hospital-wide operational activation of Cleveland Clinic using AI and technology Francine De Stoppelaar, Healthcare Director, Hospital Operations & Activation, Cleveland Clinic London

      Francine is not only also the Clinic’s Director of Pharmacy, but she has been integral in developing this brand new, fully-automated, state-of-the-art, 200-bed hospital, which is directly linked to Cleveland Clinic in Ohio, USA. It provides the very latest medical innovations, state-of-the-art technology and is the first hospital to be fully digital, automated, and paperless. Francine will share the insights gained during this digitalisation process, including lessons learned and challenges overcome.

      • Francine De Stoppelaar, Healthcare Director, Hospital Operations & Activation, Cleveland Clinic London

    • 11:50 - 12:10
      HEADLINE USE CASE: How UMC Utrecht offers smart healthcare through the use of integrated diagnostics and machine learning Dr. ir. Hermen Jan van Ree MBA, Director Digital Health, UMC Utrecht

      Hermen Jan will share the latest and greatest from his Applied Data Science Team, ranging from clinical AI solutions such as Sleep Well Baby for neonatal intensive care units and the automated, fully digital Glasgow Coma Scale to operational AI solutions such as Speech-to-EMR and No-Show-Prediction. His call-to-action is to collaborate internationally in developing safe and sound AI solutions for health care. Let’s shift from code to clinic together!

      • Dr. ir. Hermen Jan van Ree MBA, Director Digital Health, UMC Utrecht

    • 12:10 - 12:30
      USE CASE: Financing and delivering better care for all: Capitalizing on the power of digital and data for health in Africa Nicole Spieker, Chief Executive Officer (CEO), PharmAccess

      Across Africa, the widespread adoption of mobile and digital technology have brought unprecedented opportunities to transform healthcare. Among others, by increasing access, reducing costs and providing real-time data to guide decision making.

      PharmAccess, along with 150 public and private partners, is harnessing this opportunity by leveraging digital and data-driven innovations to improve access to basic, affordable, and quality healthcare services for all. This session will exhibit how digital innovations, data and connectivity are leapfrogging health sector development in Africa. It will showcase high-impact solutions, including value-based care models that ensure scarce resources are channeled to drive better health outcomes for patients.

      • Nicole Spieker, Chief Executive Officer (CEO), PharmAccess

    • 12:30 - 12:50
      USE CASE: Improving global health equity while doing social good Mark Pinnes, Director - Strategic Partnerships (Europe & Middle East), IndiVillage Pvt Ltd

      (12:30-12:50) 

      • Mark Pinnes, Director - Strategic Partnerships (Europe & Middle East), IndiVillage Pvt Ltd

  • TRACK 2: AI UNDER THE HOOD: WORKSHOPS
    • 11:30 - 12:30
      WORKSHOP 1: Innovation in health delivery: improving health through data Johannes Boch, Director of Population Health, Novartis Foundation
      Peter Speyer, Head of Data, Analytics & AI, Novartis Foundation

      The potential of using digital and data solutions to improve population health is acknowledged widely. Cardiovascular disease is the world’s leading cause of death. They take almost 18 million lives per year, most of them preventable, and with up to 80% of them occurring in low and middle income countries. Cardiovascular health depends on a complex system of determinants, from age and genetics to behaviors and social determinants of health, the conditions in which we are born, grow, live, work and age. We will introduce a framework and jointly debate opportunities for innovation in measuring and addressing these determinants.

       

      • Johannes Boch, Director of Population Health, Novartis Foundation

      • Peter Speyer, Head of Data, Analytics & AI, Novartis Foundation

  • 12:50 - 13:50
    LUNCH & NETWORKING MEET-UP 13:00-13:30 - Clinicians in Imaging: Expo Area - No need to pre-register. No set agenda. Just come, introduce yourself, and have a chat!

    MEET-UP 13:00-13:30 – Clinicians: Expo Area

    No need to pre-register. No set agenda. Just come, introduce yourself, and have a chat!

    • MEET-UP 13:00-13:30 - Clinicians in Imaging: Expo Area - No need to pre-register. No set agenda. Just come, introduce yourself, and have a chat!

  • INTELLIGENT HEALTH: PLENARY
    • 13:50 - 14:10
      HEADLINER: Building the next generation of health products - Precision Consumer Health Aquil Harjivan, R&D Head - Digital Health, Bayer Consumer Health
      • Aquil Harjivan, R&D Head - Digital Health, Bayer Consumer Health

    • 14:10 - 14:30
      HEADLINER: Charting the Path to Health Equity in the AI Healthcare Era Elizabeth Hampson, Partner - Life Sciences and Health Care Strategy and Analytics, Deloitte

      Health equity is the fair and just opportunity for every individual to achieve their full potential in all aspects of health and well-being. As AI increasingly plays a role in how we diagnose diseases, discover new treatments and engage with patients, it is crucial that we design solutions that explicitly consider and address the dynamics between health equity and AI. This entails for example representative (genomic) data sets to mitigate bias in treatment efficacy or AI enabling personalized care at a fraction of the cost for underserved groups. Join us to hear more insights and ideas to promote health equity through trustworthy AI and take part in creating an impact that matters for the Future of Health

      • Elizabeth Hampson, Partner - Life Sciences and Health Care Strategy and Analytics, Deloitte

    • 14:30 - 14:50
      HEADLINER: Journey of Intelligence Matthias Pfister, Head of Development Team, Optical Data Science, Helbling Technik

       The talk will highlight the evolution of artificial intelligence in diagnostics with a focus of what is possible today and what may be the next disruptive emerging technology in the field. Today’s capabilities of AI are illustrated by presenting a technology development that enables bringing retina health monitoring from the clinic to the patient’s home. Furthermore, the challenges and limitations of today’s AI are explored.The technology outlook will consist of an introduction to neuromorphic computing, analog computing and memristors.

      • Matthias Pfister, Head of Development Team, Optical Data Science, Helbling Technik

    • 14:50 - 15:30
      PANEL DISCUSSION: Discussing the potential benefits of aggregating scientific data while addressing patient privacy and ethical concerns Nicholas Accomando, VP, Chief Compliance & Privacy Officer at Flatiron Health (Affiliate of the Roche Group)
      Prof. Dr. Milan Petković, Head of AI & Data Science R&D, Connected Care, Philips
      Dr Katrin Crameri, Director Personalized Health Informatics, SIB Swiss Institute of Bioinformatics
      Moderator:
      Rasmus Sten Andersen, Principal Data Scientist, Amsterdam Data Collective
      • Nicholas Accomando, VP, Chief Compliance & Privacy Officer at Flatiron Health (Affiliate of the Roche Group)

      • Prof. Dr. Milan Petković, Head of AI & Data Science R&D, Connected Care, Philips

      • Dr Katrin Crameri, Director Personalized Health Informatics, SIB Swiss Institute of Bioinformatics

      • Moderator:

      • Rasmus Sten Andersen, Principal Data Scientist, Amsterdam Data Collective

    • 15:30 - 15:55
      HEADLINER: Improving Outcomes- Leveraging AI across care continuum of patient care Sunil Dadlani, EVP, Chief Information & Digital Officer & Chief Cyber Security Officer, Atlantic Health System

      Dr Dadlani will explore the critical role of AI in healthcare and how it impacts patient outcomes throughout the healthcare consumer care continuum journey. He will look at healthcare disruptions and digital acceleration, the benefits and risk of AI, how you can introduce trustworthy & ethical AI in healthcare settings, a scenario of patient through care continuum and care coordination, and the role of different technologies such as AI, ML, NLP, digital twins and clinical decision support systems, and 3D modelling in enabling real-time healthcare with positive patient outcomes

      • Sunil Dadlani, EVP, Chief Information & Digital Officer & Chief Cyber Security Officer, Atlantic Health System

  • TRACK 1: INNOVATION STAGE: AI HEALTH TRANSFORMERS Chair:
    Frank Dannacher, Director, AI & Data Practice Lead for Life Science and Healthcare, Deloitte Switzerland
    • 13:50 - 14:10
      INNOVATION INSIGHT: Health AI with Constrained Data Collection: Technologies and Applications Jiangtao Wang, Associate Professor of Health Data Science, Research Centre for Intelligent Healthcare, Coventry University

      Continuous sensing and monitoring of the health status or related factors of individuals and groups, and high-precision reasoning and prediction of future states have become important research issues in the field of digital intelligent health. This talk will focus on how to comprehensively use machine learning and intelligent data collection technologies including active learning, data augmentation, self-supervised learning, and multi-task transfer learning, with our recent novel population health monitoring research in collaboration with public health team from National Health Service (NHS).

      • Jiangtao Wang, Associate Professor of Health Data Science, Research Centre for Intelligent Healthcare, Coventry University

    • 14:10 - 14:30
      INNOVATION INSIGHT: LLM-powered Data Extraction for Regulatory Documents Benjamin von Deschwanden,Co-Founder and Chief Product Officer (CPO), Acodis AG

      Large language models (LLMs) are going to change how Regulatory teams work with documents. In this session, we will use two practical use cases to demonstrate how Generative AI can be used to extract data from documents more efficiently and to gather insights from documents without the risk of hallucination.

      • Benjamin von Deschwanden,Co-Founder and Chief Product Officer (CPO), Acodis AG

    • 14:30 - 14:50
      HEADLINE INNOVATION INSIGHT: How to address the regulatory challenges of AI and ML in healthcare: forget about the past Dr. Andrea Biasiucci, CEO, confinis
      Dr Dario Motti, Head of Digital Health, confinis

      In this session, Andrea & Dario will present the latest trends in the regulatory challenges that affect small and large manufacturers of AI in healthcare, providing practical tips on how to adequately address and solve them. This session is targeted to an audience that develops new AI products and that has to face the uncertainties of regulated markets.

      • Dr. Andrea Biasiucci, CEO, confinis

      • Dr Dario Motti, Head of Digital Health, confinis

    • 14:50 - 15:10
      INNOVATION INSIGHT: Wellness to Well-being: Smitch’s Blueprint for the Future Sanath Kumar, CEO, Smitch

      Smitch isn’t just about predicting the future; we’re actively sculpting it. We foresee a realm where healthcare shifts from mere wellness to holistic well-being. Central to this transformative vision is the “Human Token”, representing the synthesis between data equity and individual narratives. By harnessing AI’s capabilities, we craft personalized health narratives, ensuring each individual’s journey is unique and reflective of their experiences. Our mantra symbolizes this transition, driving a paradigm shift that focuses on the complete health spectrum—how we look, feel, and perform, so that preventive health isn’t about something in the distant future, but helps you right here and now!

      • Sanath Kumar, CEO, Smitch

    • 15:10 - 15:30
      INNOVATION INSIGHT: Unlock privacy-sensitive data with AI-Generated Synthetic Data in Healthcare Wim Kees Janssen, Co-Founder & CEO, Syntho

      The potential of data-driven innovation with AI in healthcare is enormous. However, healthcare data is the most privacy sensitive data and consequently, this data cannot simply be used and shared. In this session, we will deepdive in how health organizations can unlock privacy-sensitive data with AI-Generated Synthetic Data to realize data-driven innovation with less risk, more data and faster data-access

      • Wim Kees Janssen, Co-Founder & CEO, Syntho

    • 15:30 - 15:40
      INNOVATION INSIGHT: Establishing Trust in Healthcare AI: A Decade of Insights Pau Rué, PhD, VP of Artificial Intelligence, Infermedica

      The transformative potential of AI in healthcare is immense, yet it hinges on the trust and acceptance of providers, practitioners, and consumers. In this session, we distill over a decade of experience in developing reliable AI solutions for healthcare, focusing on the challenges posed by powerful emerging technologies like Deep Learning and Large Language Models.

      • Pau Rué, PhD, VP of Artificial Intelligence, Infermedica

    • 15:40 - 16:00
      INNOVATION INSIGHT: Developing customized AI solutions for skincare diagnostics and disease prediction models Yurii Kryvoborodov, Head of AI & Data Consulting, Unicsoft

      With skincare diagnostics, quick action is often key to a successful outcome. But you don’t need to have AI engineers in-house or an extensive datasets to build effective ML models for your healthcare business. Ground-breaking AI and technology innovation can offer high accuracy in tackling diverse challenges from computer vision for skin disease detection to comprehensive prediction algorithms in various healthcare domains, offering an effective streamlined process for accurate diagnosis and easy tracking and analysis of skin dynamics over time

      • Yurii Kryvoborodov, Head of AI & Data Consulting, Unicsoft

  • TRACK 2: AFRICAN STARTUP PITCHES
    • 13:55 - 13:55
      Host: Sharon Batamuriza, Program Director, Bridge for Billions
      • Sharon Batamuriza, Program Director, Bridge for Billions

    • 13:55 - 14:07
      Startup 1 Peace Ndoli Iraguha, COO & Co-founder, Lifesten
      • Peace Ndoli Iraguha, COO & Co-founder, Lifesten

    • 14:10 - 14:22
      Startup 2 Dr William Mapham, CEO, Vula Mobile
      • Dr William Mapham, CEO, Vula Mobile

    • 14:25 - 14:37
      Startup 3 Nelson Igbiriki, CEO & Co-Founder, Medtech Africa
      • Nelson Igbiriki, CEO & Co-Founder, Medtech Africa

    • 14:40 - 14:52
      Startup 4 Jelle Schuitemaker, CMO & Co-Founder, GOAL 3
      • Jelle Schuitemaker, CMO & Co-Founder, GOAL 3

    • 14:55 - 15:07
      Startup 5 Sami Chagar, COO & Co-Founder, Docthus Healthtech
      • Sami Chagar, COO & Co-Founder, Docthus Healthtech

    • 15:10 - 15:22
      Startup 6 Dr Bethel Dereje MD, Gynecologic Oncologist, Founder and CEO, WeCare Digital Health
      • Dr Bethel Dereje MD, Gynecologic Oncologist, Founder and CEO, WeCare Digital Health

    • 15:25 - 15:37
      Startup 7 Dr Rob Korom, Chief Medical Officer, Penda Health
      • Dr Rob Korom, Chief Medical Officer, Penda Health

    • 15:40 - 15:52
      Startup 8 Conrad Tankou, CEO, GIC Space
      • Conrad Tankou, CEO, GIC Space

  • 15:55 - 16:10
    REFRESHMENTS & NETWORKING
  • INTELLIGENT HEALTH: PLENARY
    • 16:10 - 16:35
      HEADLINER: The importance of continuous access to patient data for AI Innovation in Healthcare Prof. Dr. Milan Petković, Head of AI & Data Science R&D, Connected Care, Philips

      Our healthcare systems are facing serious challenges ranging from an ageing population and pandemics to an increasing number of chronically ill people and workforce shortages. Data and Artificial Intelligence (AI) technologies can lead the way in transforming the healthcare sector and helping address these difficult challenges. This is not merely a future vision, but a reality, which we are shaping today. In this talk, Milan will share proof points of the beneficial applications of AI in Healthcare and discuss the importance of continuous collection and aggregation of data for boosting AI innovations in Healthcare, while addressing patient privacy and ethical concerns.

      • Prof. Dr. Milan Petković, Head of AI & Data Science R&D, Connected Care, Philips

    • 16:35 - 17:10
      PANEL DISCUSSION: Exploring the real and potential impact of Generative AI and LLMs on the healthcare industry Mona Flores, Global Head of Medical AI, Nvidia
      Aditya Kudumala, Principal (Partner), Deloitte
      Nicholas Kelley, Director Data Science & A.I. Innovation, Chief Digital Office, Novartis
      Rachel Dunscombe, CEO OpenEHR, Visiting Professor Imperial College and Digital Health Advisor
      Moderator:
      Alexander Finlayson, CEO & Founder, Nye Health, NHS Primary Care Doctors & Doll Fellow, Oxford University
      • Mona Flores, Global Head of Medical AI, Nvidia

      • Aditya Kudumala, Principal (Partner), Deloitte

      • Nicholas Kelley, Director Data Science & A.I. Innovation, Chief Digital Office, Novartis

      • Rachel Dunscombe, CEO OpenEHR, Visiting Professor Imperial College and Digital Health Advisor

      • Moderator:

      • Alexander Finlayson, CEO & Founder, Nye Health, NHS Primary Care Doctors & Doll Fellow, Oxford University

    • 17:10 - 17:35
      HEADLINER: From product to experiences to achieve better outcomes powered by AI Marco Giannitrapani, VP Global Data & Analytics (Commercial), Roche

      Marco will share a couple of examples on innovating customer experience, leveraging some of the latest technology in the HCP as well as patient engagements.

      • Marco Giannitrapani, VP Global Data & Analytics (Commercial), Roche

  • TRACK 2: AFRICAN STARTUP PITCHES
    • 16:10 - 16:10
      Host: Sharon Batamuriza, Program Director, Bridge for Billions
      • Sharon Batamuriza, Program Director, Bridge for Billions

    • 16:15 - 16:27
      Startup 9 Dr Joseph Olowe, Founder & CEO, Doktorconnect
      • Dr Joseph Olowe, Founder & CEO, Doktorconnect

    • 16:30 - 16:42
      Startup 10 Kidist Tesfaye, Chief Executive Officer, YeneHealth
      • Kidist Tesfaye, Chief Executive Officer, YeneHealth

    • 16:45 - 16:57
      Startup 11 Babajide Oke, CEO & Founder, Render Health
      • Babajide Oke, CEO & Founder, Render Health

    • 17:00 - 17:12
      Startup 12 Naom Monari, Founder, Bena Care
      • Naom Monari, Founder, Bena Care

    • 17:15 - 17:27
      Startup 13 Mayoro Diagne, COO, Baamtu
      • Mayoro Diagne, COO, Baamtu

  • 17:35 -
    CLOSE OF SUMMIT DAY ONE
  • Thursday 14th
  • 08:00 - 09:00
    REGISTRATION
  • 09:00 - 09:10
    WELCOME Inspired Minds Sarah Porter, CEO and Founder, InspiredMinds! UN Advisor, LAWS Main Stage
    • Sarah Porter, CEO and Founder, InspiredMinds! UN Advisor, LAWS

  • 09:10 - 09:20
    WELCOME and chairs' opening remarks Alexander Finlayson, CEO & Founder, Nye Health, NHS Primary Care Doctors & Doll Fellow, Oxford University
    Maxine Mackintosh, Co- Founder, One HealthTech     Main Stage
    • Alexander Finlayson, CEO & Founder, Nye Health, NHS Primary Care Doctors & Doll Fellow, Oxford University

    • Maxine Mackintosh, Co- Founder, One HealthTech

  • 09:20 - 09:45
    HEADLINER: From Data to Treatment: The Role of Generative AI in Advancing Precision Health Discovery and Delivery Elena Bonfiglioli, Global Business Leader for Healthcare, Pharma and Life Sciences, Microsoft Main Stage

    Microsoft and OpenAI have been paving the way to bring generative AI to the forefront of the healthcare industry, working through flagship collaborations like the one recently announced with Epic. in this session we will explore early adoption cases of Generative AI to transform experiences and ignite insights the vast and yet still siloed health data landscape, and discuss the transformative potential of CoPilot solutions to securely unlock the productivity pools in R&D. We will delve into how foundation models interpret complex datasets, from genetic profiles to clinical records, and extrapolate patterns that were once hidden. The culmination of this process results in the creation of highly individualized treatment plans, ensuring that the right treatment reaches the right patient at the right time. We have entered a new era in precision health, and it becomes imperative to understand and harness the power of Generative AI, from organisational capabilities to technology adoption, governance and business strategies

    • Elena Bonfiglioli, Global Business Leader for Healthcare, Pharma and Life Sciences, Microsoft

  • 09:45 - 10:20
    PANEL DISCUSSION: Taking a multidisciplinary approach to product development – why including the patient and clinician voices holds the key to connected health and building trust Helge Buess, Associate Director Population Health, Novartis Foundation
    Hanno Ronte, Partner, Deloitte
    Prof Somaya Ben Allouch, Head of Digital Life Research Group, Amsterdam University of Applied Sciences; Endowed Professor of Human-System Interaction for Health & Wellbeing, University of Amsterdam
    Moderator:
    Caoimhe Vallely-Gilroy, Director of Healthcare Innovation, DayOne     Main Stage
    • Helge Buess, Associate Director Population Health, Novartis Foundation

    • Hanno Ronte, Partner, Deloitte

    • Prof Somaya Ben Allouch, Head of Digital Life Research Group, Amsterdam University of Applied Sciences; Endowed Professor of Human-System Interaction for Health & Wellbeing, University of Amsterdam

    • Moderator:

    • Caoimhe Vallely-Gilroy, Director of Healthcare Innovation, DayOne

  • 10:20 - 10:45
    HEADLINER: Revolutionizing surgery with surgical operating systems: The future of integrated healthcare Ozanan Meireles, Surgeon at Massachusetts General Hospital; Director MGH Surgical Artificial Intelligence and Innovation Laboratory (SAIIL); Assistant Professor of Surgery, Harvard Medical School Main Stage

    In an era of technological disruption, healthcare stands on the cusp of revolutionary change. This talk introduces the concept of a Surgical Operating System (SOS), a groundbreaking framework designed to unify surgical teams, operating rooms, and patient data—akin to how a computer OS manages resources. We’ll explore key theoretical features such as real-time resource allocation, IoT device management, and predictive analytics. These innovations offer potential solutions to current challenges in surgical efficiency and patient outcomes, making SOS more than just an idea—it’s a blueprint for the next generation of healthcare. Join us to delve into this transformative concept and its potential to set new benchmarks in healthcare excellence. Be part of the conversation that could shape the future of medical practice.

    • Ozanan Meireles, Surgeon at Massachusetts General Hospital; Director MGH Surgical Artificial Intelligence and Innovation Laboratory (SAIIL); Assistant Professor of Surgery, Harvard Medical School

  • 10:45 - 11:15
    REFRESHMENTS & NETWORKING
  • INTELLIGENT HEALTH: PLENARY
    • 11:15 - 11:35
      AI IN ACTION HEADLINER: Transforming Healthcare with Large Language Models: Solving Real-World Challenges in Clinical Practice and Patient Engagement Veysel Kocaman, Head of Data Science (Healthcare), John Snow Labs

      The world of natural language processing is expanding, and the potential it brings to the healthcare industry is nothing short of revolutionary. The speaker, Veysel, an expert in the field of machine learning and AI applications in healthcare, will shed light on how large language models like ChatGPT, LLaMA, and Falcon are being trained to navigate the complex semantics of biomedical and clinical text

      • Veysel Kocaman, Head of Data Science (Healthcare), John Snow Labs

    • 11:35 - 12:15
      PANEL DISCUSSION: Cybersecurity in Healthcare: Best practice for dealing with the plethora of ever-increasing threats in a timely and financially-viable manner Sunil Dadlani, EVP, Chief Information & Digital Officer & Chief Cyber Security Officer, Atlantic Health System
      Sofia Martinez Gomez, Cyber Security Expert, Roche Diagnostics
      Dr. Fred Mpala, Chief Security Officer, Evidation
      Moderator:
      Vincent de Crayencour, Head of International Development, CyberPeace Institute
      • Sunil Dadlani, EVP, Chief Information & Digital Officer & Chief Cyber Security Officer, Atlantic Health System

      • Sofia Martinez Gomez, Cyber Security Expert, Roche Diagnostics

      • Dr. Fred Mpala, Chief Security Officer, Evidation

      • Moderator:

      • Vincent de Crayencour, Head of International Development, CyberPeace Institute

    • 12:15 - 12:35
      USE CASE: Eyes Wide Open: Hopkins' Transformative AI for Unbiased Digital Retinal Imaging Dr Aisha Rahim, Medical Executive and Director, Johns Hopkins HealthCare

      Calling all healthcare enthusiasts and tech aficionados. Join Dr Aisha Rahim for an enlightening presentation that delves into the cutting-edge world of AI and healthcare at Hopkins. Discover how Hopkins, a renowned healthcare institution, is revolutionizing patient care through AI-powered digital retinal imaging. Learn how they tackle bias challenges head-on, ensuring equitable and unbiased healthcare for all. Unravel the secrets behind their groundbreaking approach, as Aisha delves into the implementation of generative AI to transform the future of medical diagnosis and treatment. Don’t miss this unique opportunity to be at the forefront of healthcare innovation and witness the powerful impact of AI on equitable patient outcomes.

      • Dr Aisha Rahim, Medical Executive and Director, Johns Hopkins HealthCare

    • 12:35 - 12:55
      USE CASE: Getting started with your first Generative AI Use Case Mostafa Ajallooeian, Engagement Director, Senior Data Scientist, Unit8 SA

      Drastically reducing R&D time is GenAI’s main footprint in healthcare now but what about other, smaller yet impactful use cases? In this session we’ll briefly explore GenAI and its growing applications in the healthcare sector. Next we’ll walk through a live demo where we leverage ChatGPT to extract, summarize and reference insights from medical journals. We’ll conclude with a healthcare client project that leveraged generative AI, its resulting business impact as well as a roadmap on how to get started with GenAI in your organization.

      • Mostafa Ajallooeian, Engagement Director, Senior Data Scientist, Unit8 SA

  • TRACK 1: PRACTICAL, REAL-WORLD AI USE CASES IN HEALTHCARE Stefan Naeff, Digital Health Care Lead for Switzerland, Deloitte Consulting AG
    • 11:15 - 11:35
      USE CASE: Challenges in the use of digital technologies in the preparedness, readiness, and response to disasters Lina Echeverri, Medical Doctor, MSc in Disaster Medicine, Consultant, Health Emergencies, CRIMEDIM - Center for Research and Training in Disaster Medicine, Humanitarian Aid and Global Health

      Digital technologies and tools in humanitarian crises, and overall disaster preparedness and response, have seen their roles in facilitating data collection and analysis, dissemination of information, support to coordination, advocacy and of course fundraising. Notwithstanding advancement in such technologies, challenges remain in their implementation and use in complex contexts as in conflicts, fragile states, and low-resource settings, where protection of data and appropriate use of context analysis cannot be guaranteed, or where poorly designed, unsustainable, and unsafe digital health products might not only be a waste of time and resources in already constraint settings, but could put at risk the wellbeing of the people they are meant to serve.

      • Lina Echeverri, Medical Doctor, MSc in Disaster Medicine, Consultant, Health Emergencies, CRIMEDIM - Center for Research and Training in Disaster Medicine, Humanitarian Aid and Global Health

    • 11:35 - 11:55
      USE CASE: The FIND validation platform: Manufacturer independent evaluations for CXR-CAD Matthew Arentz, MD MPH; Lead – Digital Health Validation Program; Senior Technical Consultant, FIND

      At FIND, the global alliance for diagnostics, we have developed a validation platform (VP) that incorporates core principles for evaluation of AI based diagnostics. This platform can perform an independent analysis of AI-diagnostics (including CXR-CAD) and inform users regarding performance in specific populations and geographies that may have differences from those an AI model was trained on. FIND, along with other partners, are evaluating the use of CXR-CAD in the diagnosis of tuberculosis,  COVID-19, and other pneumonia, as initial areas of focus. However, the platform is built to allow evaluation of other AI based diagnostics as products evolve. Findings can better inform health systems prior to purchase, and can be iterative, allowing for evaluation of different software versions, limiting unnecessary investment in version updates.  In this talk, the speaker will cover key aspects of the validation platform and its use in evaluation and validation of performance of CXR-CAD for the World Health Organization and expansion to use with other stakeholders.

      • Matthew Arentz, MD MPH; Lead – Digital Health Validation Program; Senior Technical Consultant, FIND

    • 11:55 - 12:15
      USE CASE: Using AI to overcome inequalities in healthcare for children Alberto Tozzi,Head of Predictive and Preventive Medicine Research Unit, Bambino Gesù Children’s Hospital, Rome

      This talk will describe the Pediatric Moonshot, a project aiming at using decentralized architectures for AI based on edge computing and federated learning. Alberto will discuss how this solution will help in providing clinical expertize where children and families have no access to specialized care. He will also discuss how such a solution is privacy preserving and sustainable. Ethical implications of AI tools for pediatrics will also be discussed.

      • Alberto Tozzi,Head of Predictive and Preventive Medicine Research Unit, Bambino Gesù Children’s Hospital, Rome

  • TRACK 2: AI UNDER THE HOOD: WORKSHOPS
    • 11:15 - 12:15
      WORKSHOP 2: Demystifying Generative AI - Shape use cases where generative AI adds real value to the Health Sector Berit Gerritzen, Ph.D., Director, AI & Data, Deloitte Consulting AG
      Antonio Russo, Innovation Leader and Partner, Head of Analytics & Cognitive, Deloitte Switzerland
      Aditya Kudumala, Principal (Partner), Deloitte
      Wolfram von Ehren, Senior Director, Deloitte

      Hands-on session with coaches from Deloitte Consulting, Legal and Cyber to help design Generative AI use cases covering business, technical and risk / legal considerations

      • Berit Gerritzen, Ph.D., Director, AI & Data, Deloitte Consulting AG

      • Antonio Russo, Innovation Leader and Partner, Head of Analytics & Cognitive, Deloitte Switzerland

      • Aditya Kudumala, Principal (Partner), Deloitte

      • Wolfram von Ehren, Senior Director, Deloitte

    • 12:15 - 13:15
      WORKSHOP 3: Accelerated framework for AI Compliance in Less Than an Hour! Kenn Milton, CEO and Founder, MyBlueLabel 

      Do you wish to develop and deliver innovative products and services but worry about maintaining compliance in the face of increasingly complex regulations? This workshop, led by MyBlueLabel, will examine how to manage regulatory requirements, from launching a new product to managing post-market activities. It will simplify the compliance process, reducing the resources required, and helping to deliver faster product launches in both the EU and USA, all whilst ensuring ethical use, data security, and transparency. All in under an hour!!

      • Kenn Milton, CEO and Founder, MyBlueLabel 

  • 12:55 - 13:45
    LUNCH & NETWORKING MEET-UP (13:05-13:35) - Healthcare data and analytics leaders: Expo Area - No need to pre-register. No set agenda. Just come, introduce yourself, and have a chat!
    • MEET-UP (13:05-13:35) - Healthcare data and analytics leaders: Expo Area - No need to pre-register. No set agenda. Just come, introduce yourself, and have a chat!

  • INTELLIGENT HEALTH: PLENARY
    • 13:45 - 14:05
      HEADLINER: Machine Learning and Generative AI in Medical Devices Lisa Falco, Lead Consultant AI & Data, Zühlke Group Gabriel Krummenacher, Head of Data Science, Zühlke Group

      The compliant development of medical devices with machine learning presents several challenges: the approach to building machine learning models is highly exploratory and characterized by empirical experimentation. To properly test and evaluate methods and training models in a way that is reproducible in a clinical setting can be difficult and the quality and quantity requirements for the data are often unclear. In this presentation, Zühlke will show how it is possible to successfully implement medical machine learning projects thanks to consistent adherence to best practices, systematic quality control and a risk-based approach. We will also discuss the new challenges of leveraging generative AI for medical applications

      • Lisa Falco, Lead Consultant AI & Data, Zühlke Group Gabriel Krummenacher, Head of Data Science, Zühlke Group

    • 14:05 - 14:25
      HEADLINER: Patient digital twins for personalised medicine Dr Darren Gates, Clinical Innovation Consultant, Alder Hey Innovation Service; Consultant Paediatric Intensivist, Alder Hey Children's Hospital

      The Digital Twin paradigm holds the potential to visualise a patient virtually. It could facilitate describing the real-time response to an intervention based on a change in patient state or patient trajectory offering both an immediate feedback loop for clinicians, as well as a reproducible record that can be interrogated alongside other similar cases. In addition to this, it could be analysed remotely, over variable timeframes, replayed, and simulated. It would serve as a patient specific communication tool where previous responses can be observed by multiple physicians and pave the way for the evaluation of medical treatments virtually. It is anticipated that this will help revise the one-size-fits-all approach that currently prevails in evidence-based medicine, for more personalised, precision interventions. In this session we’ll explore what a patient digital twin is, how it might be used and current progress in development.

      • Dr Darren Gates, Clinical Innovation Consultant, Alder Hey Innovation Service; Consultant Paediatric Intensivist, Alder Hey Children's Hospital

    • 14:25 - 14:40
      HEADLINER: Next-Gen Humanoid Care to assist with healthy aging in older adults Shubha Koneru, SVP - Healthcare Strategy & Partnerships, Machani Robotics
      • Shubha Koneru, SVP - Healthcare Strategy & Partnerships, Machani Robotics

    • 14:40 - 15:25
      PANEL DISCUSSION: Driving health equity through data Gaurica Chacko, Vice President and Global Head, Life Sciences Consulting, Wipro
      Rodrigo Saucedo-Martinez, Head of Digital Health, Carlos Slim Foundation
      Peter van Ooijen, Professor of AI in Radiotherapy, Department of Radiotherapy; Machine Learning Expert & Coordinator Machine Learning Lab, Data Science Center in Health (DASH), University Medical Center Groningen
      Moderator:
      Sarah Des Rosiers, Director, Health Equity, Novartis Foundation

      Bringing together data from health and health-influencing sectors and applying advanced analytics and AI can provide decision makers with insights about the true drivers of health and equity. These insights can help city authorities make more informed decisions about how to target health resources toward the interventions that positively impact the health of the greatest number of people. And, importantly, narrow existing health inequities.

      • Gaurica Chacko, Vice President and Global Head, Life Sciences Consulting, Wipro

      • Rodrigo Saucedo-Martinez, Head of Digital Health, Carlos Slim Foundation

      • Peter van Ooijen, Professor of AI in Radiotherapy, Department of Radiotherapy; Machine Learning Expert & Coordinator Machine Learning Lab, Data Science Center in Health (DASH), University Medical Center Groningen

      • Moderator:

      • Sarah Des Rosiers, Director, Health Equity, Novartis Foundation

    • 15:25 - 15:45
      HEADLINER USE CASE: Elevating the accuracy of diagnosis, doctor productivity and patient satisfaction with Apollo Clinical Intelligence Engine Dr Sujoy Kar, Chief Medical Information Officer & Vice President, Apollo Hospitals

      Apollo Hospitals, one of Asia’s largest healthcare providers, launched its Apollo Clinical Intelligence Engine, an AI clinical decision support tool designed to improve the accuracy of diagnosis, doctor productivity, and patient satisfaction. With over 1,300 conditions and 800 symptoms in its vocabulary, the tool uses AI and ML techniques to analyse vast amounts of data and help healthcare professionals identify patterns that may be missed otherwise. It is powered by a knowledge base built and maintained by an in-house team of over 500 Apollo doctors and specialists and is available to all qualified, practising doctors in India on the Apollo 24|7 platform.

      • Dr Sujoy Kar, Chief Medical Information Officer & Vice President, Apollo Hospitals

  • TRACK 1: INNOVATION STAGE: AI HEALTH TRANSFORMERS Chair:
    Frank Dannacher, Director, AI & Data Practice Lead for Life Science and Healthcare, Deloitte Switzerland
    • 13:45 - 14:05
      INNOVATION INSIGHT: Redefining Healthcare by harnessing the power of in silico technology Luca Emili, Founder & CEO, InSilicoTrials

      (13:45 – 14:05)

      This session will feature insights from Luca Emili, CEO of InSilicoTrials, elaborating on how the company’s Modeling and Simulation platform is innovating medical product development and regulatory processes. Employing advanced in silico trials, the platform leverages artificial intelligence (AI) and computational modeling to simulate, predict, and evaluate the safety and efficacy of new drugs and medical devices. The discussion will highlight how AI-driven virtual trials provide a more efficient and cost-effective alternative to traditional clinical trials and present some of the new solutions we are working on: AI tools for patients’ cohort detection and clinical trial matching, Big Data for building virtual patient models using omics and clinical data, in silico microbiome.

      • Luca Emili, Founder & CEO, InSilicoTrials

    • 14:05 - 14:25
      INNOVATION INSIGHT: AI in Medical Education Kathrin Biernat, CEO, 123 Sonography GmbH

      Rule-based AI tools have long entered healthcare and the medical field, and AI is significantly changing the field and setting a new ground. What is the 4th wave of artificial intelligence bringing to medical education and information acquisition? How will we and our behavior change? Which methods, models, and products will dominate the educational market? What formats and when will we learn (and consume)?

      • Kathrin Biernat, CEO, 123 Sonography GmbH

    • 14:25 - 14:35
      INNOVATION INSIGHT: Future Design of Modern Healthcare Systems: Evolution of Real World Data Volker Rudolph, Founder & Developer, MedRepo

      Real World Data is essential for Artificial Intelligence (another word for Real World Evidence). Real World Data and Real World Evidence belong together, as they are a pair. Using Real World Data means that you can feed AI Systems openly and publicly with anonymized data.

      • Volker Rudolph, Founder & Developer, MedRepo

    • 14:35 - 15:45
      STARTUPS SHOWCASE Startups:
      Dr Zaid Al-fagih, Co-Founder & CEO, Rhazes AI Better Medicine
      Chris Mckee, Managing Director, Better Medicine
      Vasileios Dimakopoulos, Co-Founder & COO, Aisthesis Medical
      Dr. Janis Reinelt, Chief Medical Officer, AICURA medical
      Christoffer Ekstrom, CEO, AI Medical Technology
      Judges:
      Frank Dannacher, Director, AI & Data Practice Lead for Life Science and Healthcare, Deloitte Switzerland
      Fabian Scheugenpflug, Investor & Senior Ventures Associate, Plug and Play Health EMEA
      Ana Bernardo Gancedo, Associate, Amadeus Capital Partners
      Lucy Setian, Director of Digital Transformation, Novartis Foundation
      Dr. Felice Burn, Head of Artificial Intelligence & Data Science, Kantonsspital Aarau AG       Track 1

      Five AI startups short-listed for our showcase get 10 minutes to pitch their business idea to four judges.

      After each pitch, judges get 5 minutes to ask questions about the venture.

      • Startups:

      • Dr Zaid Al-fagih, Co-Founder & CEO, Rhazes AI Better Medicine

      • Chris Mckee, Managing Director, Better Medicine

      • Vasileios Dimakopoulos, Co-Founder & COO, Aisthesis Medical

      • Dr. Janis Reinelt, Chief Medical Officer, AICURA medical

      • Christoffer Ekstrom, CEO, AI Medical Technology

      • Judges:

      • Frank Dannacher, Director, AI & Data Practice Lead for Life Science and Healthcare, Deloitte Switzerland

      • Fabian Scheugenpflug, Investor & Senior Ventures Associate, Plug and Play Health EMEA

      • Ana Bernardo Gancedo, Associate, Amadeus Capital Partners

      • Lucy Setian, Director of Digital Transformation, Novartis Foundation

      • Dr. Felice Burn, Head of Artificial Intelligence & Data Science, Kantonsspital Aarau AG

  • TRACK 2: AFRICAN STARTUP PITCHES
    • 13:45 - 14:45
      Host: M. Christelle Igihozo, HealthTech Hub Africa - Senior Program Manager, Bridge for Billions
      Elizabeth Adeshina, Founder, Wazima Health
      Dr. Jerome Nshimiyimana, Founder and CEO, Jo Grp Ltd
      Dr William Mapham, CEO, Vula Mobile

      Host: Bridge for Billions

      Startups:

      (13:50 – 14-02)

      Dr. Jerome Nshimiyimana, Founder and CEO, Jo Grp Ltd

      (14:05 – 14:17)

      Elizabeth Adeshina, Founder, Wazima Health

      (14:20 – 14:32)

      Dr William Mapham, CEO, Vula Mobile

      • M. Christelle Igihozo, HealthTech Hub Africa - Senior Program Manager, Bridge for Billions

      • Elizabeth Adeshina, Founder, Wazima Health

      • Dr. Jerome Nshimiyimana, Founder and CEO, Jo Grp Ltd

      • Dr William Mapham, CEO, Vula Mobile

    • 14:50 - 15:50
      WORKSHOP 4: The Path to GenAi: From Data to Intelligence Clare Bornstein, Advanced Analytics Platform Lead, Global Manufacturing & Supply, Takeda
      Nishant Sinha, Director, AI & Automation, Deloitte Switzerland
      Susan Tillmann, Head Data, Analytics and Digital Global Manufacturing & Supply, Takeda

      The secret to GenAi – meticulous data preparation. GenAi brings incredible potential to deliver transformative business value. With all the hype, it is easy to forget about the less exciting but highly critical preparation work – ensuring access to quality, reliable and trustworthy data for automated model development. Join us as we share our experience, practical strategies and insights as we embark on the journey from data to intelligence.

      • Clare Bornstein, Advanced Analytics Platform Lead, Global Manufacturing & Supply, Takeda

      • Nishant Sinha, Director, AI & Automation, Deloitte Switzerland

      • Susan Tillmann, Head Data, Analytics and Digital Global Manufacturing & Supply, Takeda

  • 15:45 - 16:05
    REFRESHMENTS & NETWORKING
  • 16:05 - 16:30
    HEADLINER: The Digital Health Revolution: Can the transformation seen in digital, decentralized clinical trials provide a faster route to informing care? Katie Baca-Motes, Co-founder and Chief Strategy Officer, The Digital Trials Center, Scripps Research/CareEvolution Main Stage

    Over the last decade, we’ve seen a rapid transformation in the way clinical research is conducted, moving away from the traditional clinical trial design which typically requires a hands-on, boots-on-the-ground model. While not all aspects of a traditional trial can be replaced, the newer digital and decentralized approach showcases new opportunities to streamline operational workflows, enhance the capture of real-world evidence, and engage participants and patients in a more meaningful way.

    This session will highlight three seminal digital clinical studies (mSTOPS, DETECT and PROGRESS) that have moved the needle beyond proof-of-concept highlighting the ability to scale and broaden participant reach, transition from observational to interventional, and implement digital health technologies for data collection beyond a limited, episodic cadence. The research efforts at Scripps Research showcase the potential for accelerating the transformation of healthcare—better prevention, faster diagnosis, improved treatments—through the continued advancement of a digital, decentralized clinical trial model which can serve as the roadmap for transforming healthcare delivery.

    • Katie Baca-Motes, Co-founder and Chief Strategy Officer, The Digital Trials Center, Scripps Research/CareEvolution

  • 16:30 - 17:00
    PANEL DISCUSSION: Reimagining the future of Healthcare with Big Tech and AI Ozanan Meireles, Surgeon at Massachusetts General Hospital; Director MGH Surgical Artificial Intelligence and Innovation Laboratory (SAIIL); Assistant Professor of Surgery, Harvard Medical School
    Sunil Dadlani, EVP, Chief Information & Digital Officer & Chief Cyber Security Officer, Atlantic Health System
    Dr Sahar Hashmi, Founder & CEO, Myriad Consulting LLC
    Moderator:
    Jan Beger, Senior Director Digital Ecosystem, GE HealthCare     Main Stage
    • Ozanan Meireles, Surgeon at Massachusetts General Hospital; Director MGH Surgical Artificial Intelligence and Innovation Laboratory (SAIIL); Assistant Professor of Surgery, Harvard Medical School

    • Sunil Dadlani, EVP, Chief Information & Digital Officer & Chief Cyber Security Officer, Atlantic Health System

    • Dr Sahar Hashmi, Founder & CEO, Myriad Consulting LLC

    • Moderator:

    • Jan Beger, Senior Director Digital Ecosystem, GE HealthCare

  • 17:00 - 17:00
    CLOSE OF INTELLIGENT HEALTH SUMMIT 2023

Don’t miss out!

Sign up now and get the latest news and ticket deals!

SUBSCRIBE NOW